Anthony Kerlavage

Dr Anthony Kerlavage

Acting Director, Center for Biomedical Informatics and IT, NCI

Dr. Kerlavage serves as the Acting Director of the National Cancer Institute’s Center for Biomedical Informatics and Information Technology (CBIIT), where he previously served as the Chief of the Cancer Informatics Branch. He has overseen programs including omics data management and analysis, cloud computing, imaging informatics, clinical trials infrastructure and decision support, and semantics and interoperability; all with a strong emphasis on open software and open data.

Prior to joining the NCI in 2011, Dr. Kerlavage spent over 25 years in the public and private sector as a leader in bioinformatics and genomics.  After his post-doctoral work at University of Pennsylvania, he spent seven years at the National Institute of Neurological Disorders and Stroke (NINDS) working on the structure of neurotransmitter receptors and on identifying genes expressed in the brain. He left the NIH to become a founding member of The Institute for Genomic Research (TIGR), focusing on informatics support for whole genome sequencing and analysis, and subsequently, Celera Genomics, where he managed their online information business. He spent several years at Applied Biosystems and Life Technologies, where he supported global customers with intelligent monitoring systems for scientific instrumentation, LIMS systems, and computational infrastructure support for next-generation sequencing technologies. Dr. Kerlavage received an MS and PhD from UC San Diego, and his undergraduate degree from Penn State, all in Chemistry.


Featured Speakers



evidera excelra genrubix signet at big data stemtrak

The event is a good opportunity for industry to come together and identify ways to understand and utilize big data in the advancement of patient care.

Dr Mark Roche, CEO, Avanti iHealth

Show the sponsors

Vote who is making waves in the industry!

Phacilitate will gather influencers and industry innovators together from across healthcare, academia, Big Pharma, government and technology innovators into an ebook. Find out more